Lv1
20 积分 2024-05-22 加入
Bortezomib plus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 Trial
6个月前
已完结
FRI-086-YI Long-term survival outcomes in patients receiving atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma: an update of the AB-real study
9个月前
已完结
FRI-086-YI Long-term survival outcomes in patients receiving atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma: an update of the AB-real study
9个月前
已完结
Efficacy of TACE in combination with sorafenib versus sorafenib or TACE alone for advanced hepatocellular carcinoma: A meta-analysis of randomized controlled trials (RCTs)
9个月前
已完结
皖公网安备34019202002308
